Among them, valproate has been shown to attenuate atherosclerosis and alleviate hepatic steatosis [90] and azoramide has been shown to improve insulin sensitivity and pancreatic β-cell function in rodent models [89]. The gene discussed is INS; the disease is Hepatic steatosis.